Tema Oncology ETFCANCETF
13F holders, Q4 2024 (December 31)3holders −2
1new positions
3sold out
$25.41avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Tema Oncology ETF (CANC) in their 13F filings, down 2 from Q3 2024. 1 opened new positions and 3 sold out. The largest holders were Thrivent Financial for Lutherans ($13.2M), Harbour Investments, Inc. ($8K) and FMR LLC ($49).
- Company
- Tema Oncology ETF
- Filed as
- TEMA ETF TRUST (Q4 2024)
- CUSIP
- 87975E701
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $49 |
| Exits | 3 | $1.3M |
All 13F filers, Q3 2024 → Q4 2024: 118,330 shares bought and 44,632 shares sold, net +73,698 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Thrivent Financial for Lutherans | 0.03% | Add +29.6% | 517,837 | $13.2M |
| Harbour Investments, Inc. | 0.00% | No change | 316 | $8K |
| FMR LLC | 0.00% | New | 2 | $49 |
"% of holder's portfolio" is CANC's weight in each manager's 13F, not the share of Tema Oncology ETF the manager owns.